PXR variants: the impact on drug metabolism and therapeutic responses
about
Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice.Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450.Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells.
P2860
PXR variants: the impact on drug metabolism and therapeutic responses
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
PXR variants: the impact on drug metabolism and therapeutic responses
@ast
PXR variants: the impact on drug metabolism and therapeutic responses
@en
PXR variants: the impact on drug metabolism and therapeutic responses
@nl
type
label
PXR variants: the impact on drug metabolism and therapeutic responses
@ast
PXR variants: the impact on drug metabolism and therapeutic responses
@en
PXR variants: the impact on drug metabolism and therapeutic responses
@nl
prefLabel
PXR variants: the impact on drug metabolism and therapeutic responses
@ast
PXR variants: the impact on drug metabolism and therapeutic responses
@en
PXR variants: the impact on drug metabolism and therapeutic responses
@nl
P2860
P3181
P1476
PXR variants: the impact on drug metabolism and therapeutic responses
@en
P2093
C. Trent Brewer
Taosheng Chen
P2860
P304
P3181
P356
10.1016/J.APSB.2016.07.002
P407
P577
2016-09-01T00:00:00Z